Pharmafile Logo
Pharmafocus logo
Advanced Search

Medical Communications

Showing 15 posts of 6402 posts found.

gsk_boronia_australia

GSK confirms £250m deal to sell experimental drug to Dermavent Sciences

July 13, 2018 Medical Communications Dermavent, GSK, Roivant, tapinarof

British company GlaxoSmithKline has announced that it will sell the rights to its experimental dermatology drug, tapinarof, to Roivant Sciences’ …
News
johnson_and_johnson_jj

J&J ordered to pay $4.68 billion to talc-powder plaintiffs

July 13, 2018 Medical Communications J&J, JJ, Johnson and Johnson, legal, talc powder

A Missouri jury has ordered the New Jersey-based healthcare company Johnson and Johnson to pay $4.69 billion to 22 women …
News

Alvogen court case causes Nevada Judge to halt execution

July 13, 2018 Medical Communications Alvogen, Nevada, court, execution, lethal injection

A Nevada Judge has temporarily prevented the use of the sedative midazolam, in the execution of the twice convicted killer …
News
takeda_usa_pharmaceuticals_u

Takeda’s Ninlaro clears Phase 3 endpoint as maintenance therapy in multiple myeloma

July 12, 2018 Medical Communications, Research and Development Ninlaro, Takeda, multiple myeloma, pharma

After making headlines with its mammoth deal to acquire Shire earlier this year, Takeda has emerged with new Phase 3 …
News
top_10_image

Top Ten most popular articles on Pharmafile.com this week

July 12, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EMA, Pfizer, Sanofi, Trump, top 10

In the week leading up to Donald Trump’s visit to the United Kingdom, the news has been dominated by the …
News
mario_saltarelli_cropped

Syntimmune appoints Pfizer, AbbVie veteran as new CMO

July 10, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AbbVie, CMO, John Hopkins University, Pfizer, Syntimmune

The Boston-based clinical biotechnology company Syntimmune has appointed Dr Mario Saltarelli as its Chief Medical Officer. Dr Saltarelli will take …
Appointment

NICE calls to limit antibiotic use in COPD over antimicrobial resistance fears

July 10, 2018 Manufacturing and Production, Medical Communications, Research and Development COPD, NICE, antimicrobial resistance, chronic obstructive pulmonary disease, pharma

NICE have published a draft antimicrobial prescribing guide recommending that healthcare professionals should consider the risk of antimicrobial resistance when …
News

Insider Interview: Biosimilars to balance the books

July 9, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Mylan, bisoimilars, multiple sclerosis

Jean-Yves Brault, Country Manager at Mylan UK, discusses how biosimilars are going to play an important role in driving down …
Feature
sicorbio

Teva to relocate US HQ to New Jersey, affecting over 1,000 jobs

July 6, 2018 Manufacturing and Production, Medical Communications Teva, US, new jersey, pharma, philadelphia

As the Israeli firm presses on with attempts to cut back on costs and streamline operations, Teva has announced plans …
News
top_10_image

Top Ten most popular articles on Pharmafile.com this week

July 6, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AbbVie, Astrazenaca, Donald Trump, Pfizer, pharma, top ten

As the first week of July comes to an end we take a look over the most popular stories of …
News
michel_porro-getty_images

Zynerba’s cannabis-based transdermal patch fails at Phase 1, shares slide 21%

July 6, 2018 Medical Communications, Research and Development GW Pharma, Zynerba, cannabidinol, cannabinol, cannabis, pharma, trial failure

As public focus on the issue of medicinal cannabis continues to grow, Zynerba Pharmaceuticals has announced that its transdermal tetrahydrocannabinol …
News

Missouri appeals court overturns $55m J&J verdict

July 6, 2018 Medical Communications, Sales and Marketing Cancer, J&J, JJ, Litigation, appeal, pharma

A $55 million verdict against the multinational pharmaceutical company Johnson & Johnson has been overturned by an appeals court in …
News
Toronto, Ontario skyline

Illegally manufactured fentanyl drives deaths in Ontario

July 5, 2018 Medical Communications Crisis, Ontario, canda, epidemic, fentanyl, opioid

Illicit forms of the powerful opioid fentanyl have been driving increased rates of opioid-related deaths in the Canadian province of …
News
pharmafocus_july-august_2018_cover

The July/August issue of Pharmafocus is now live!

July 4, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bristol-Myers Squibb, Elizabeth Holmes, NHS, Sanofi, Theranos, UK, ambien, manufacturing compliance, opdivo, patient recruitment, patient retention, pharma

The new July/August edition of Pharmafocus is now available to read online.
News
deborah_standing_cropped_web

Lundbeck appoints new President and CEO

July 3, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing appointment, ludbeck, pharma

The Danish pharmaceutical company Lundbeck has announced that the company’s Board of Directors have appointed Dr Deborah Dunshire as Lunbeck’s …
Appointment
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025